Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Sep;98(36):e16935.
doi: 10.1097/MD.0000000000016935.

Clinical feasibility of imaging with indocyanine green combined with carbon nanoparticles for sentinel lymph node identification in papillary thyroid microcarcinoma

Xing Zhang  1 , Yan-Ping Shen  2 , Jia-Gen Li  1 , Gun Chen  3
Affiliations
Randomized Controlled Trial

Clinical feasibility of imaging with indocyanine green combined with carbon nanoparticles for sentinel lymph node identification in papillary thyroid microcarcinoma

Xing Zhang et al. Medicine (Baltimore). 2019 Sep.

Abstract

Background: Although several previous studies demonstrated the feasibility and efficacy of indocyanine green (ICG) for thyroid cancer surgery, ICG was administered through venous injection and focused on parathyroid gland protection. We thus aimed to study the feasibility of imaging using ICG combined with carbon nanoparticles (CNs) in the identification of sentinel lymph nodes (SLNs) in patients diagnosed with papillary thyroid microcarcinoma (PTMC).

Methods: Two approaches were applied to detect lymph nodes in PTMC surgery. Patients were randomized into 2 groups. ICG and CNs were injected into the thyroid in Group A. In Group B, only CNs was injected. Black-stained or fluorescent nodes observed using near-infrared fluorescence imaging systems were defined as SLNs. SLN and central lymph node (CLN) dissection was completed in both groups. The pathological and postoperative outcomes were compared between 2 groups.

Results: There were 40 patients in Group A and 60 in Group B. A total of 138 SLNs were identified; 72 and 66 SLNs were detected and dissected in Groups A and B, respectively. The number of SLNs identified (per patient) in Group A was higher than that in Group B (P = .027). The number of harvested CLNs was 161 and 192 in Groups A and B, respectively, out of which 45 and 48 lymph nodes with metastasis were confirmed by permanent pathology. The CLN metastatic rate in Group A was higher than that in Group B (P = .048).

Conclusion: Imaging using ICG combined CNs is feasible and safe for SLN identification in PTMC patients. Compared with using only CNs, more SLNs can be removed and more metastatic lymph nodes can be confirmed when using the combined method. Although the combined method appears to accurately stage tumors, further research is needed.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
(A) NIR. (B) Fluorescence detecting probe. NIR = near-infrared fluorescence imaging systems.
Figure 2
Figure 2
(A) White arrows show black-stained SLNs by carbon nanoparticles; yellow arrow shows the parathyroid gland not stained black. (B) The image was obtained using near-infrared fluorescence imaging systems. White arrow shows fluorescent SLNs; black arrow shows the parathyroid gland; yellow arrow shows the thyroid gland. SLNs = sentinel lymph nodes.
Figure 3
Figure 3
(A) Removed specimen. White arrows show SLNs; and the yellow arrow shows the thyroid gland. (B) An image of the same specimen was obtained using near-infrared fluorescence imaging systems. White arrows show SLNs and yellow arrow shows the thyroid gland. SLNs = sentinel lymph nodes.
See this image and copyright information in PMC

References

    1. McCarthy M. US thyroid cancer rates are epidemic of diagnosis not disease, study says. BMJ 2014;24:1743. - PubMed
    1. Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid 2014;24:472–9. - PMC - PubMed
    1. Wang TS, Sosa JA. Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. Nat Rev Endocrinol 2018;14:670–83. - PubMed
    1. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1999;114:1050–8. - PubMed
    1. Shaha AR. Thyroid cancer: extent of thyroidectomy. Cancer Control 2000;7:240–5. - PubMed

Publication types

MeSH terms

Supplementary concepts